664 results on '"Walder, Ken"'
Search Results
2. Network-based drug repurposing for schizophrenia
3. Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in male mice with obesity
4. Association of Genetic Variation Within UBL5 with Phenotypes of Metabolic Syndrome
5. Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen
6. CaMKK2 as an emerging treatment target for bipolar disorder
7. Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
8. Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorder
9. Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity
10. A plasma protein signature associated with cognitive function in men without severe cognitive impairment
11. Diet and depression: future needs to unlock the potential
12. The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes
13. Diet and depression: exploring the biological mechanisms of action
14. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis
15. The role of metformin as a treatment for neuropsychiatric illness
16. Brain derived neurotrophic factor in perioperative neurocognitive disorders: Current evidence and future directions
17. Common effects of bipolar disorder medications on expression quantitative trait loci genes
18. Genetic polymorphism in BIN1 rather than APOE is associated with poor recognition memory among men without dementia
19. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders
20. The potential of baicalin to enhance neuroprotection and mitochondrial function in a human neuronal cell model
21. Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial
22. The lipid paradox in neuroprogressive disorders: Causes and consequences
23. The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders
24. Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: Moderation by childhood trauma severity
25. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
26. Recombinant Balsamin induces apoptosis in liver and breast cancer cells via cell cycle arrest and regulation of apoptotic pathways
27. Effects of antipsychotic drugs on energy metabolism
28. Association of mood disorder and bone health with cognitive function among healthy ageing men
29. The compensatory antioxidant response system with a focus on neuroprogressive disorders
30. Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
31. Modulation of high fat diet-induced microbiome changes, but not behaviour, by minocycline
32. The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis
33. Impact of Mood Disorder History and Bone Health on Cognitive Function Among Men Without Dementia
34. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management
35. Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
36. Author Response: Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
37. Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
38. Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression
39. The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases
40. Prevalence of BFDV in wild breeding Platycercus elegans
41. The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications
42. Species, sex and geographic variation in chlamydial prevalence in abundant wild Australian parrots
43. Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
44. A model of the mitochondrial basis of bipolar disorder
45. Seasonal fluctuation of beak and feather disease virus (BFDV) infection in wild Crimson Rosellas (Platycercus elegans)
46. Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression
47. Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis
48. Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
49. Identification of reversible and druggable pathways to improve beta-cell function and survival in Type 2 diabetes
50. Correction to: Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.